Skip to content

A proof-of-concept study of ultrasound stimulation of the neck to enhance anti-shock efficacy

A proof-of-concept study of ultrasound stimulation of the neck to enhance anti-shock efficacy

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093480
Enrollment
Unknown
Registered
2024-12-05
Start date
2023-12-05
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shock

Interventions

Standard anti-shock therapy group:Normal saline 500 mL was given for rapid rehydration and norepinephrine intravenous pumping was given to achieve a target systolic blood pressure of 120 mmHg
LIPU stimulation + standard anti-shock therapy group:Low-intensity pulsed ultrasound stimulation of the neck was given, and 500 mL of normal saline fluid was given at the same time, and norepinephrine

Sponsors

Tianjin Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with traumatic hypovolemic shock aged >=18 years admitted to ICU and NICU; 2. Patients with invasive arterial blood pressure monitoring; 3. Patients with systolic blood pressure <=100mmHg and urine volume <0.5ml/kg/h; 4. Patients with mild or moderate traumatic hypovolemic shock with 1<=SI (shock index) <=2; 5. Patients with complete case information. 6. The subjects understood and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with unstable conditions and estimated survival time of less than 24 hours; 2. Patients with non-traumatic shock; 3. Perioperative patients; 4. Patients in pregnancy; 5. Patients with carotid artery plaques who are at risk of LIPU stimulation; 6. Patients who refuse or are unwilling to cooperate with this subject; 7. Patients who are considered unsuitable to join the study by the researchers. The general condition of the patient is extremely poor, such as: multiple organ failure; severe cardiopulmonary complications, etc.

Design outcomes

Primary

MeasureTime frame
Time to reach target blood pressure after LIPU stimulation;Norepinephrine dosage to achieve target after LIPU stimulation;

Secondary

MeasureTime frame
mRS scores of patients after 1 month and 3 months;

Countries

China

Contacts

Public ContactRongcai Jiang; Chenrui Wu; Yu Tian

Tianjin Medical University General Hospital

1870301339@qq.com+86 136 7211 6556

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026